{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,24]],"date-time":"2026-02-24T17:10:42Z","timestamp":1771953042132,"version":"3.50.1"},"reference-count":36,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2015,10,1]],"date-time":"2015-10-01T00:00:00Z","timestamp":1443657600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100001215","name":"La Trobe University","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100001215","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Discovery Early Career Researcher Award"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuroscience Letters"],"published-print":{"date-parts":[[2015,10]]},"DOI":"10.1016\/j.neulet.2015.09.019","type":"journal-article","created":{"date-parts":[[2015,9,23]],"date-time":"2015-09-23T18:48:46Z","timestamp":1443034126000},"page":"72-76","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":18,"special_numbering":"C","title":["Chronic estrogen and progesterone treatment inhibits ketamine-induced disruption of prepulse inhibition in rats"],"prefix":"10.1016","volume":"607","author":[{"given":"Maarten","family":"van den Buuse","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rebecca L.","family":"Mingon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrea","family":"Gogos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.neulet.2015.09.019_bib0005","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.neuropharm.2012.12.009","article-title":"Sex differences in the antidepressant-like effects of ketamine","volume":"70","author":"Carrier","year":"2013","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neulet.2015.09.019_bib0010","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1186\/1744-9081-8-61","article-title":"GABAergic neuroactive steroids: a new frontier in bipolar disorders?","volume":"8","author":"Carta","year":"2012","journal-title":"Behav. Brain Funct.: BBF"},{"key":"10.1016\/j.neulet.2015.09.019_bib0015","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1177\/0269881107077718","article-title":"(+\/\u2212) Ketamine-induced prepulse inhibition deficits of an acoustic startle response in rats are not reversed by antipsychotics","volume":"21","author":"Cilia","year":"2007","journal-title":"J. Psychopharmacol."},{"key":"10.1016\/j.neulet.2015.09.019_bib0020","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1016\/S0022-3565(25)38157-7","article-title":"Evidence for involvement of brain dopamine and other mechanisms in the behavioral action of the N-methyl-d-aspartic acid antagonist MK-801 in control and 6-hydroxydopamine-lesioned rats","volume":"265","author":"Criswell","year":"1993","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.neulet.2015.09.019_bib0025","doi-asserted-by":"crossref","first-page":"3663","DOI":"10.1007\/s00213-014-3664-5","article-title":"Ketamine administration in depressive disorders: a systematic review and meta-analysis","volume":"231","author":"Fond","year":"2014","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.neulet.2015.09.019_bib0030","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1007\/s002130100811","article-title":"Pharmacological studies of prepulse inhibition models of sensorimotor gating deficits in schizophrenia: a decade in review","volume":"156","author":"Geyer","year":"2001","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.neulet.2015.09.019_bib0035","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1124\/jpet.109.162123","article-title":"Estrogen treatment blocks 8-OH-DPAT- and apomorphine-induced disruptions of prepulse inhibition: involvement of dopamine D1 or D2 serotonin 5-HT1A , 5-HT2A or 5-HT7 receptors","volume":"333","author":"Gogos","year":"2010","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.neulet.2015.09.019_bib0040","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1007\/s00213-011-2389-y","article-title":"The role of estrogen and testosterone in female rats in behavioral models of relevance to schizophrenia","volume":"219","author":"Gogos","year":"2012","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.neulet.2015.09.019_bib0045","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1124\/jpet.103.061432","article-title":"Estrogen and progesterone prevent disruption of prepulse inhibition by the serotonin-1A receptor agonist 8-OH-DPAT","volume":"309","author":"Gogos","year":"2004","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.neulet.2015.09.019_bib0050","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/S0306-4530(02)00125-7","article-title":"Gender differences in schizophrenia","volume":"28","author":"H\u00e4fner","year":"2003","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.neulet.2015.09.019_bib0055","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1093\/bja\/82.4.603","article-title":"Stereospecific effects of ketamine on dopamine efflux and uptake in the rat nucleus accumbens","volume":"82","author":"Hancock","year":"1999","journal-title":"Br. J. Anaesth."},{"key":"10.1016\/j.neulet.2015.09.019_bib0060","doi-asserted-by":"crossref","first-page":"5383","DOI":"10.1523\/JNEUROSCI.5443-07.2008","article-title":"Ketamine, but not phencyclidine, selectively modulates cerebellar GABA(A) receptors containing alpha6 and delta subunits","volume":"28","author":"Hevers","year":"2008","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neulet.2015.09.019_bib0065","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1016\/S0031-9384(98)00098-5","article-title":"Sensorimotor gating changes across the estrous cycle in female rats","volume":"64","author":"Koch","year":"1998","journal-title":"Physiol. Behav."},{"key":"10.1016\/j.neulet.2015.09.019_bib0070","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1046\/j.1471-4159.1999.0730839.x","article-title":"Modulation of the mesolimbic dopamine system by glutamate: role of NMDA receptors","volume":"73","author":"Kretschmer","year":"1999","journal-title":"J. Neurochem."},{"key":"10.1016\/j.neulet.2015.09.019_bib0075","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1001\/archpsyc.65.8.955","article-title":"Estrogen in severe mental illness: a potential new treatment approach","volume":"65","author":"Kulkarni","year":"2008","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.neulet.2015.09.019_bib0080","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1177\/026988110401800302","article-title":"Gender differences and the effects of ketamine in healthy volunteers","volume":"18","author":"Lees","year":"2004","journal-title":"J. Psychopharmacol."},{"key":"10.1016\/j.neulet.2015.09.019_bib0085","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/0014-2999(91)90228-I","article-title":"Comparison of pharmacodynamic effects of the non-competitive NMDA receptor antagonists MK-801 and ketamine in pigs","volume":"192","author":"L\u00f6scher","year":"1991","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.neulet.2015.09.019_bib0090","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1038\/sj.npp.1300952","article-title":"Neuroactive steroids are altered in schizophrenia and bipolar disorder: relevance to pathophysiology and therapeutics","volume":"31","author":"Marx","year":"2006","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neulet.2015.09.019_bib0095","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/S0028-3908(98)00163-4","article-title":"Differential actions of dizocilpine (MK-801) on the mesolimbic and mesocortical dopamine systems: role of neuronal activity","volume":"38","author":"Mathe","year":"1999","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neulet.2015.09.019_bib0100","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/0361-9230(95)02144-2","article-title":"Effects of MK-801 on spontaneous and amphetamine- stimulated dopamine release in striatum measured with in vivo microdialysis in awake rats","volume":"40","author":"Miller","year":"1996","journal-title":"Brain Res. Bull."},{"key":"10.1016\/j.neulet.2015.09.019_bib0105","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1016\/S0893-133X(99)00127-X","article-title":"Effects of ketamine, MK-801, and amphetamine on regional brain 2-deoxyglucose uptake in freely moving mice","volume":"22","author":"Miyamoto","year":"2000","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neulet.2015.09.019_bib0110","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1111\/j.1360-0443.2011.03576.x","article-title":"Independent Scientific Committee on, ketamine use: a review","volume":"107","author":"Morgan","year":"2012","journal-title":"Addiction"},{"key":"10.1016\/j.neulet.2015.09.019_bib0115","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.jad.2013.11.014","article-title":"A review of ketamine in affective disorders: current evidence of clinical efficacy, limitations of use and pre-clinical evidence on proposed mechanisms of action","volume":"156","author":"Naughton","year":"2014","journal-title":"J. Affective Disord."},{"key":"10.1016\/j.neulet.2015.09.019_bib0120","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1016\/j.euroneuro.2008.06.005","article-title":"Glutamatergic dysfunction in schizophrenia: from basic neuroscience to clinical psychopharmacology","volume":"18","author":"Paz","year":"2008","journal-title":"Eur. Neuropsychopharmacol."},{"key":"10.1016\/j.neulet.2015.09.019_bib0125","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1007\/s00737-002-0003-3","article-title":"Estrogen effects in schizophrenia and their potential therapeutic implications\u2014review","volume":"5","author":"Riecher-R\u00f6ssler","year":"2002","journal-title":"Arch. Women Ment. Health"},{"key":"10.1016\/j.neulet.2015.09.019_bib0130","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/S0306-4530(02)00064-1","article-title":"Neuroactive steroids: mechanisms of action and neuropsychopharmacological properties","volume":"28","author":"Rupprecht","year":"2003","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.neulet.2015.09.019_bib0135","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1007\/s002130050916","article-title":"Assessment of neuroleptic-like properties of progesterone","volume":"143","author":"Rupprecht","year":"1999","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.neulet.2015.09.019_bib0140","series-title":"Ketamine, Handbook of Experimental Pharmacology","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1007\/978-3-540-74806-9_15","author":"Sinner","year":"2008"},{"key":"10.1016\/j.neulet.2015.09.019_bib0145","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.tacc.2014.03.002","article-title":"Ketamine\u2014more mechanisms of action than just NMDA blockade","volume":"4","author":"Sleigh","year":"2014","journal-title":"Trends Anaesth. Crit. Care"},{"key":"10.1016\/j.neulet.2015.09.019_bib0150","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1001\/archpsyc.63.12.1325","article-title":"Startle gating deficits in a large cohort of patients with schizophrenia","volume":"63","author":"Swerdlow","year":"2006","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.neulet.2015.09.019_bib0155","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1192\/S0007125000293598","article-title":"Glutamatergic aspects of schizophrenia","volume":"174","author":"Tamminga","year":"1999","journal-title":"Br. J. Psychiatry"},{"key":"10.1016\/j.neulet.2015.09.019_bib0160","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1093\/schbul\/sbp132","article-title":"Modeling the positive symptoms of schizophrenia in genetically modified mice: pharmacology and methodology aspects","volume":"36","author":"van den Buuse","year":"2010","journal-title":"Schizophr. Bull."},{"key":"10.1016\/j.neulet.2015.09.019_bib0165","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/S0014-2999(01)01139-6","article-title":"Estrogen increases prepulse inhibition of acoustic startle in rats","volume":"425","author":"Van den Buuse","year":"2001","journal-title":"Eur J. Pharmacol."},{"issue":"44","key":"10.1016\/j.neulet.2015.09.019_bib0170","article-title":"Neurosteroids and GABA-A receptor function","volume":"2","author":"Wang","year":"2011","journal-title":"Front. Endocrinol."},{"key":"10.1016\/j.neulet.2015.09.019_bib0175","doi-asserted-by":"crossref","first-page":"199","DOI":"10.2165\/00023210-200620030-00003","article-title":"Ketamine: from medicine to misuse","volume":"20","author":"Wolff","year":"2006","journal-title":"CNS Drugs"},{"key":"10.1016\/j.neulet.2015.09.019_bib0180","doi-asserted-by":"crossref","first-page":"7104","DOI":"10.1073\/pnas.83.18.7104","article-title":"The anticonvulsant MK-801 is a potent N-methyl-d-aspartate antagonist","volume":"83","author":"Wong","year":"1986","journal-title":"Proc. Natl. Acad. Sci. U. S. A."}],"container-title":["Neuroscience Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304394015301452?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304394015301452?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,5,30]],"date-time":"2025-05-30T19:46:55Z","timestamp":1748634415000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0304394015301452"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,10]]},"references-count":36,"alternative-id":["S0304394015301452"],"URL":"https:\/\/doi.org\/10.1016\/j.neulet.2015.09.019","relation":{},"ISSN":["0304-3940"],"issn-type":[{"value":"0304-3940","type":"print"}],"subject":[],"published":{"date-parts":[[2015,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Chronic estrogen and progesterone treatment inhibits ketamine-induced disruption of prepulse inhibition in rats","name":"articletitle","label":"Article Title"},{"value":"Neuroscience Letters","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neulet.2015.09.019","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Ireland Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}